1. Home
  2. MDXG vs ECPG Comparison

MDXG vs ECPG Comparison

Compare MDXG & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • ECPG
  • Stock Information
  • Founded
  • MDXG 2006
  • ECPG 1998
  • Country
  • MDXG United States
  • ECPG United States
  • Employees
  • MDXG N/A
  • ECPG N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • ECPG Finance Companies
  • Sector
  • MDXG Health Care
  • ECPG Finance
  • Exchange
  • MDXG Nasdaq
  • ECPG Nasdaq
  • Market Cap
  • MDXG 1.0B
  • ECPG 905.2M
  • IPO Year
  • MDXG N/A
  • ECPG 1999
  • Fundamental
  • Price
  • MDXG $7.12
  • ECPG $48.07
  • Analyst Decision
  • MDXG Buy
  • ECPG Strong Buy
  • Analyst Count
  • MDXG 1
  • ECPG 3
  • Target Price
  • MDXG $12.00
  • ECPG $61.67
  • AVG Volume (30 Days)
  • MDXG 1.2M
  • ECPG 231.6K
  • Earning Date
  • MDXG 10-29-2025
  • ECPG 11-05-2025
  • Dividend Yield
  • MDXG N/A
  • ECPG N/A
  • EPS Growth
  • MDXG N/A
  • ECPG N/A
  • EPS
  • MDXG 0.27
  • ECPG N/A
  • Revenue
  • MDXG $393,442,000.00
  • ECPG $1,560,869,000.00
  • Revenue This Year
  • MDXG $19.01
  • ECPG $27.55
  • Revenue Next Year
  • MDXG $2.36
  • ECPG $5.84
  • P/E Ratio
  • MDXG $26.29
  • ECPG N/A
  • Revenue Growth
  • MDXG 14.77
  • ECPG 17.52
  • 52 Week Low
  • MDXG $5.79
  • ECPG $26.45
  • 52 Week High
  • MDXG $10.14
  • ECPG $51.77
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.92
  • ECPG 59.31
  • Support Level
  • MDXG $7.23
  • ECPG $41.10
  • Resistance Level
  • MDXG $7.63
  • ECPG $50.18
  • Average True Range (ATR)
  • MDXG 0.41
  • ECPG 1.85
  • MACD
  • MDXG -0.03
  • ECPG 0.49
  • Stochastic Oscillator
  • MDXG 29.68
  • ECPG 70.32

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.

Share on Social Networks: